Abstract
No public abstract is available from the verified source records.
Chaithanya Jeganathan, Peter Mbewe, Eric Chu, Andrew McLean‐Tooke
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
A systematic review on SARS‐CoV‐2‐associated fungal coinfections
10.1002/jmv.27358 · 2022
Multicenter epidemiologic study of coronavirus disease‐associated mucormycosis, India
10.3201/eid2709.210934 · 2021
T‐cells of invasive candidiasis patients show patterns of T‐cell‐exhaustion suggesting checkpoint blockade as treatment option
10.1016/j.jinf.2021.12.009 · 2021
Nivolumab plus interferon‐gamma in the treatment of intractable mucormycosis
10.1016/s1473-3099(16)30541-2 · 2017
Immune checkpoint blockade for aspergillosis and mucormycosis coinfection
2021
Interferon‐gamma immunotherapy in a patient with refractory disseminated candidiasis
10.1097/inf.0000000000000909 · 2015
No additional external references are available.